S0307 Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer.
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Alexander H Paterson, MD, FRCP
Tom Baker Cancer Centre - Calgary
Study Chair - Carla I. Falkson, MD
University of Alabama at Birmingham
Study Chair - Elizabeth C. Dees, MD
UNC Lineberger Comprehensive Cancer Center
Study Chair - James N. Ingle, MD
Mayo Clinic
Study Chair - Julie R. Gralow, MD
Seattle Cancer Care Alliance
Study Chair - Mark J. Clemons, MD
Toronto Sunnybrook Regional Cancer Centre
Study Chair - Robert B. Livingston, MD
University of Arizona
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
No facility list is in our current data snapshot for this study. The registry record on ClinicalTrials.gov ↗ carries any published locations. Why? →
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2005
- Primary completion
- 31 Dec 2017
- Completion
- 29 Mar 2021
- Last update posted
- 2 Jul 2021
- Registered enrollment
- 6,097
- Registry id
- NCT00127205
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.